Tumor Markers Millions Recovered Nationwide

Mesothelioma Tumor Markers

Tumor markers, also referred to as biomarkers, are proteins produced by tumor cells that can be measured. These substances are also manufactured by normal cells, but not in as large a quantity as that produced by tumor cells. Tumor markers are found in bodily fluids like blood and urine.

Do Tumor Markers Provide a Definitive Diagnosis of Mesothelioma?

In an article titled “Biomarkers for Malignant Pleural Mesothelioma: Current Status”, published in 2008 in Molecular Diagnosis and Therapy, researchers noted that biomarkers are useful for early diagnosis of the disease, determining the prognosis, and predicting how well patients are responding to treatment. However, the chief difficulty in making use of biomarkers is that the typical ones like cytokeratins and proteins found on the surface of cells do not differentiate malignant pleural mesothelioma from other types of malignancies or non-malignant conditions.

Although osteopontin, mesothelin, and megakaryocyte potentiating factor (MPF) are the most promising of the recently discovered biomarkers, they still present certain problems. Osteopontin is not a biomarker that is specific to mesothelioma, mesothelin and MPF do not detect sarcomatoid or biphasic mesothelioma cell types.

Researchers have tried using panels made up of a set of biomarkers, but this didn’t improve diagnostic accuracy. Research into profiling molecules is just at its beginning stages and is not useful in daily clinical practice.

A variety of biomarkers have been evaluated in body fluids and tumor tissue for their value as indicators of prognosis, but none of these play a real role in clinical practice. Information regarding predictive biomarkers is very limited.

The value of biomarkers is still an important question that needs to be addressed. That’s why these researchers made the following recommendations:

Additional prospective studies, in large and independent samples of patients, with rigorous statistical methodology and standardized laboratory techniques are now warranted to validate and define the precise value of diagnostic and prognostic MPM (malignant pleural mesothelioma) biomarkers. Future research efforts should focus on biomarkers predictive of the efficacy and toxicity of standard chemotherapy.

New Research Suggests that SMRP Levels may Hold the Key to Diagnosing Mesothelioma

Japanese researchers have found that soluble mesothelin-related peptide (SMRP) is extremely sensitive to mesothelioma, but it does not always detect every cell subtype. In a study titled Exploratory study on the detection of markers for diagnosing early-stage malignant mesothelioma, published May 2011 in Nihon Eiseigaku Zasshi (Japanese Journal of Hygiene), they noted that SMRP levels measured in pleural fluid were elevated not only in advanced stage malignant pleural mesothelioma , but also in early stage disease.

Circulating tumor cells (CTCs) and circulating endothelial cells (CECs) were good additional markers of disease progression, but they were not always accurate in diagnosing the disease in its early stages. A cell analysis with gene profiling is more effective in diagnosing early stage mesothelioma.

The Food and Drug Administration approved a test to determine if mesothelioma has progressed.

On January 24, 2007, the Food and Drug Administration (FDA) approved the MESOMARK™ test for patients who have been diagnosed with malignant mesothelioma with epithelioid features, and who are under treatment after surgery. It measures the amount of soluble mesothelin related peptides (SMRPs) in a patient’s blood sample to determine whether the disease has gotten worse.

We Take Our Clients' Cases Personal

Helping Victims of Mesothelioma Is Why We Do What We Do
  • Your firm has made this stressful process easy and comfortable for me.

    “In this difficult time for me, everyone in your office has been helpful and supportive in ensuring that not only are our objectives with my case met but also that my personal needs are accommodated.”

    - Stephen
  • I couldn’t have done it without you.

    “My case was complex, but you untangled the details of my asbestos exposure so that they were clear in court.”

    - Sam
  • The professionals at Shrader & Associates did the work, hassle free, and ensured I was able to leave a legacy for my family.

    “I hesitated to file suit because I thought going to trial would be a hassle. The professionals at Shrader & Associates did the work, hassle-free, and ensured I was able to leave a legacy for my family ...”

    - Raymond
  • Your team stood by me throughout the entire process.

    “The future looks a bit brighter for my family now.”

    - Frank
  • Thanks to you, the grief of my loss would have been almost unbearable otherwise.

    “The wonderful things you have done for us, the things you have made possible for my family, the doors you have opened – I will always be grateful.”

    - Brian
/

Experience You Can Count On

Our Awards & Accolades

  • American Association for Justice Leaders Forum
  • Million Dollar Advocates Forum
  • American Association for Justice
  • AV Peer Reviewed Rated
  • Top 40 Under 40
  • Super Lawyers Rising Stars
  • Super Lawyers
  • Mesopthelioma Applied Research Foundation
  • Illionois Trial Lawyers Assocation
  • MTLA
  • Texas Trial Lawyers Association
  • American Association for Justice Leaders Forum 2021

Choosing the Right Law Firm is an Important & Personal Decision

Why Shrader & Associates?
  • AWARD-WINNING

    Our skilled approach to the practice of law has resulted in top ratings & awards from renowned legal organizations.

  • RESPECTED

    Our attorneys have been invited into some of the most prestigious and recognized professional associations in the U.S.

  • RECOGNIZED

    We’ve been featured on local and national news programs for our legal knowledge and winning results.

  • PROVEN

    To date, we’ve secured countless million-dollar results for clients located throughout the country.

The Right Team 
Makes a Difference

Mesothelioma cases require technical knowledge and an understanding of complex laws. An attorney with experience trying these claims and substantial resources to leverage on your behalf is your best bet to having a strong case. We are nationally recognized for providing quality representation to mesothelioma patients and their families.